TNF-α Blockade Efficiently Reduced Severe Intestinal Damage in Necrotizing Enterocolitis

REFERENCES

• Lin PW, Nasr TR, Stoll BJ. Necrotizing enterocolitis: recent scientific advances in pathophysiology and prevention. Semin Perinatol. 2008;32:70–82.
   PubMed Web of Science ®Google Scholar
• Josef N, Walker WA. Necrotizing enterocolitis. N Engl J Med. 2011;364:255–264.
   PubMed Web of Science ®Google Scholar
• Thompson AM, Bizzarro MJ. Necrotizing enterocolitis in newborns: pathogenesis, prevention and management. Drugs. 2008;68:1227–1238.
   PubMed Web of Science ®Google Scholar
• Hsueh W, Caplan MS, Qu XW, et al. Neonatal necrotizing enterocolitis: clinical considerations and pathogenetic concepts. Pediatr Dev Pathol. 2003;6:6–23.
   PubMed Web of Science ®Google Scholar
• Carter BM. Treatment outcomes of necrotizing enterocolitis for preterm infants. J Obstet Gynecol Neonatal Nurs. 2007;36:377–384.
   PubMed Web of Science ®Google Scholar
• Hunter CJ, De Plaen IG. Inflammatory signaling in NEC: Role of NF-κB, cytokines and other inflammatory mediators. Pathophysiology. 2014;21:55–65.
   PubMedGoogle Scholar
• Martin CR, Walker WA. Intestinal immune defences and the inflammatory response in necrotising enterocolitis. Semin Fetal Neonatal Med. 2006;11:369–77.
   PubMed Web of Science ®Google Scholar
• Homsi E, Andreazzi DD, Faria JB, et al. TNF-α-mediated cardiorenal injury after rhabdomyolysis in rats. Am J Physiol Renal Physiol. 2015;308:F1259–F1267.
   PubMed Web of Science ®Google Scholar
• Cano-Martínez D, Román ID, T Lobo MV, et al. Effect of Infliximab in oxidised serum albumin levels during experimental colitis. Biomarkers. 2014;19:693–701.
   PubMed Web of Science ®Google Scholar
• Aydin I, Kalkan Y, Ozer E, et al. The protective effect of infliximab on cisplatin-induced intestinal tissue toxicity. Eur Rev Med Pharmacol Sci. 2014;18:2076–2083.
   PubMed Web of Science ®Google Scholar
• Akdogan RA, Kalkan Y, Tumkaya L, et al. Influence of infliximab pretreatment on ischemia/reperfusion injury in rat intestine. Folia Histochem Cytobiol. 2014;52:36–41.
   PubMed Web of Science ®Google Scholar
• Zani A, Cordischi L, Cananzi M, et al. Assessment of a neonatal rat model of necrotizing enterocolitis. Eur J Pediatr Surg. 2008;18:423–426.
   PubMed Web of Science ®Google Scholar
• Caplan MS, Hedlund E, Adler L, et al. Role of asphyxia and feeding in a neonatal rat model of necrotizing enterocolitis. Pediatr Pathol. 1994;14:1017–1028.
   PubMed Web of Science ®Google Scholar
• Jilling T, Lu J, Jackson M, et al. Intestinal epithelial apoptosis initiates gross bowel necrosis in an experimental rat model of neonatal necrotizing enterocolitis. Pediatr Res. 2004;55:622–629.
   PubMed Web of Science ®Google Scholar
• Devrim Erdinç, Çetin Meltem, Namuslu Mehmet, et al. Oxidant stress due to non ionic low osmolar contrast medium in rat kidney. Indian J Med Res. 2009;130:433–436.
   PubMed Web of Science ®Google Scholar
• Lowry OH, Rosebrough NJ, Farr AL, et al. Protein measurement with the folin phenol reagent. J Biol Chem. 1951;193:265–275.
   PubMed Web of Science ®Google Scholar
• Erel O. A new automated colorimetric method for measuring total oxidant status. Clin Biochem. 2005;38:1103–1111.
   PubMed Web of Science ®Google Scholar
• Draper HH, Hadley M. Malondialdehyde determination as index of lipid peroxidation. Methods Enzymol. 1990;186:421–431.
   PubMed Web of Science ®Google Scholar
• Gulec M, Gurel A, Armutcu F. Vitamin E protects against oxidative damage caused by formaldehyde in the liver and plasma of rats. Mol Cell Biochem. 2006;290:61–67.
   PubMed Web of Science ®Google Scholar
• Tihan DN, Erbil Y, Seven R, et al. The effect of glutamine on oxidative damage in an experimental abdominal compartment syndrome model in rats. Ulus Travma Acil Cerrahi Derg. 2011;17:1–8.
   PubMed Web of Science ®Google Scholar
• Caplan MS, Sun XM, Hseuh W, et al. Role of platelet activating factor and tumor necrosis factor-alpha in neonatal necrotizing enterocolitis. J Pediatr. 1990;116:960–964.
   PubMed Web of Science ®Google Scholar
• Tan X, Hsueh W, Gonzalez-Crussi F. Cellular localization of tumor necrosis factor (TNF)-alpha transcripts in normal bowel and in necrotizing enterocolitis. TNF gene expression by Paneth cells, intestinal eosinophils, and macrophages. Am J Pathol. 1993; 142:1858–1865.
   PubMed Web of Science ®Google Scholar
• Martius G, Cameron S, Rave-Fränk M, et al. The anti-TNF-α antibody infliximab inhibits the expression of fat-transporter-protein FAT/CD36 in a selective hepatic-radiation mouse model. Int J Mol Sci. 2015;16:4682–4697.
   PubMed Web of Science ®Google Scholar
• Chu WM. Tumor necrosis factor. Cancer Lett. 2013;328:222–225.
   PubMed Web of Science ®Google Scholar
• Jia Z, Babu PV, Nallasamy P, et al. Genistein inhibits TNF-α-induced endothelial inflammation through the protein kinase pathway A and improves vascular inflammation in C57BL/6 mice. Int J Cardiol. 2013;168:2637–2645.
   PubMed Web of Science ®Google Scholar
• Claud EC, Walker WA. Hypothesis: inappropriate colonization of the premature intestine can cause neonatal necrotizing enterocolitis. FASEB J. 2001;15:1398–1403.
   PubMed Web of Science ®Google Scholar
• Davies MJ. Myeloperoxidase-derived oxidation: mechanisms of biological damage and its prevention. J Clin Biochem Nutr. 2011;48:8–19.
   PubMed Web of Science ®Google Scholar
• Pech T, von Websky M, Ohsawa I, et al. Intestinal Regeneration, Residual Function and Immunological Priming Following Rescue Therapy After Rat Small Bowel Transplantation. Am J Transplant. doi:10.1111/j.1600–6143.2012.04262.
   Google Scholar
• Nankervis CA, Giannone PJ, Reber KM. The neonatal intestinal vasculature: contributing factors to necrotizing enterocolitis. Semin Perinatol. 2008;32:83–91.
   PubMed Web of Science ®Google Scholar
• Rogers S, Witz G, Anwar M, et al. Antioxidant capacity and oxygen radical diseases in the preterm newborn. Arch Pediatr Adolesc Med. 2000;154:544–548.
   PubMedGoogle Scholar
• Lee JW, Davis JM. Future applications of antioxidants in premature infants. Curr Opin Pediatr. 2011;22:161–166.
   Web of Science ®Google Scholar
• Perry BC, Soltys D, Toledo AH, et al. Tumor necrosis factor-α in liver ischemia/reperfusion injury. J Invest Surg. 2011;24:178–188.
   PubMed Web of Science ®Google Scholar
• Romero FJ, Bosch-Morell F, Romero MJ, et al. Lipid peroxidation products and antioxidants in human disease. Environ Health Perspect. 1998;106:1229–1234.
   PubMed Web of Science ®Google Scholar
• Vancurova I, Bellani P, Davidson D. Activation of nuclear factor-kappaB and its suppression by dexamethasone in polymorphonuclear leukocytes: newborn versus adult. Pediatr Res. 2001; 49:257–262.
   PubMed Web of Science ®Google Scholar
• Kilpinen S, Henttinen T, Lahdenpohja N, et al. Signals leading to the activation of NF-kappa B transcription factor are stronger in neonatal than adult T lymphocytes. Scand J Immunol. 1996; 44:85–88.
   PubMed Web of Science ®Google Scholar
• Cui W, Li LX, Sun CM, et al. Tumor necrosis factor alpha increases epithelial barrier permeability by disrupting tight junctions in Caco-2 cells. Braz J Med Biol Res. 2010;43:330–337.
   PubMed Web of Science ®Google Scholar
• Ma TY, Iwamoto GK, Hoa NT, et al. TNF-alpha-induced increase in intestinal epithelial tight junction permeability requires NF-kappa B activation. Am J Physiol Gastrointest Liver Physiol. 2004;286:G367–G376.
   PubMed Web of Science ®Google Scholar
• Juuti-Uusitalo K, Klunder LJ, Sjollema KA, et al. Differential effects of TNF (TNFSF2) and IFN-γ on intestinal epithelial cell morphogenesis and barrier function in three-dimensional culture. PLoS One. 2011;6:e22967.
   PubMed Web of Science ®Google Scholar
• Li WD, Jia L, Ou Y, et al. Infliximab: protective effect to intestinal barrier function of rat with acute necrosis pancreatitis at early stage. Pancreas. 2013;42:366–367.
   PubMed Web of Science ®Google Scholar
• Van Antwerp DJ, Martin SJ, Verma IM, et al. Inhibition of TNF-induced apoptosis by NF-kappa B. Trends Cell Biol. 1998;8:107–111.
   PubMed Web of Science ®Google Scholar
• Alvarez S, Blanco A, Fresno M, et al. TNF-α contributes to caspase-3 independent apoptosis in neuroblastoma cells: role of NFAT. PLoS One. 2011;6:e16100.
   PubMed Web of Science ®Google Scholar
• Schmelz K, Wieder T, Tamm I, et al. Tumor necrosis factor alpha sensitizes malignant cells to chemotherapeutic drugs via the mitochondrial apoptosis pathway independently of caspase-8 and NF-kappaB. Oncogene. 2004;23:6743–6759.
   PubMed Web of Science ®Google Scholar
• Benderska N, Chakilam S, Hugle M,et al. Apoptosis signalling activated by TNF in the lower gastrointestinal tract–review. Curr Pharm Biotechnol. 2012;13:2248–2258.
   PubMed Web of Science ®Google Scholar